A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 31/337 (2006.01) A61K 31/513 (2006.01) A61K 31/704 (2006.01) A61K 38/30 (2006.01)
Patent
CA 2422625
New methods for the treatment of human disease are provided. IGFBP-3 is administered together with a co-administered agent to subjects having disease, thereby alleviating the symptoms of the disease, under conditions where administration of IGFBP-3 alone at the maximum practicable dose has no measurable beneficial effect on the disease condition.
Cette invention concerne de nouvelles méthodes de traitement de maladies de l'homme. On administre la protéine IGFBP-3 en même temps qu'un agent à des sujets atteints de maladie dans le but d'atténuer les symptômes de ladite maladie dans des conditions ou l'administration d'IGFBP-3 seule à la dose maximum praticable n'a pas d'effet bénéfiques notable sur l'état de la maladie.
Bioexpertise Llc
Borden Ladner Gervais Llp
LandOfFree
Method for use of igf-binding protein for selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for use of igf-binding protein for selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for use of igf-binding protein for selective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1399388